ZIM Laboratories Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ZIM Laboratories Limited generated cash of $162,782,000, which is less than the previous year. Cash used in financing activities reached the amount of $595,340,000 last year. Net change in cash is therefore $31,797,000.
Cash Flow
| 2016 | 219.42M | -117.34M | -103.48M |
|---|---|---|---|
| 2018 | 366.12M | -258.31M | -97.37M |
| 2020 | 219.15M | -190.58M | -25.09M |
| 2021 | 318.51M | -58.80M | -259.74M |
| 2023 | 375.19M | -362.03M | 5.45M |
| 2024 | 162.78M | -730.12M | 595.34M |
ZIMLAB.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 64.20M | 34.20M | 14.61M | 4.99M | 4.24M | 8.83M |
Operating activities | ||||||
Net income | 172.46M | 353.55M | 154.12M | 686K | 249.35M | 53.62M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 159.51M | 174.69M | 157.89M | 144.11M | 97.89M | 87.56M |
Stock-based compensation expense | 0 | 0 | 0 | 152K | 2.38M | 6.25M |
| Deferred income tax benefit | 0 | 0 | 0 | 152K | 2.38M | 6.25M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -71.36M | 26.94M | -129.15M | 170.94M | -21.01M | -111.88M |
Inventories | -275.56M | 215.78M | 20.41M | -13.36M | -160.95M | 83.80M |
Accounts payable | 79.08M | -371.14M | 26.32M | -152.00M | 210.93M | -171.36M |
Cash generated by operating activities | 162.78M | 375.19M | 318.51M | 219.15M | 366.12M | 219.42M |
Investing activities | ||||||
Purchases Of Investments | -2.83M | -200K | -2.03M | -19.46M | -12.61M | -30.72M |
Investments In Property Plant And Equipment | -739.23M | -366.67M | -64.77M | -185.27M | -285.16M | -131.56M |
Acquisitions Net | 0 | 200K | 59K | -500K | 305K | -34.73M |
Cash generated by investing activities | -730.12M | -362.03M | -58.80M | -190.58M | -258.31M | -117.34M |
Financing activities | ||||||
Common Stock Issued | 214.02M | -4.75M | 612K | 612K | 306K | 0 |
Payments for dividends | -493K | -585K | -244K | -9.11M | -7.39M | -67K |
Repurchases of common stock | 0 | 4.75M | 23.45M | 0 | 0 | 0 |
Repayments of term debt | 473.69M | 9.62M | -234.94M | 29.25M | -25.28M | -37.73M |
Cash used in financing activities | 595.34M | 5.45M | -259.74M | -25.09M | -97.37M | -103.48M |
Net Change In Cash | 31.79M | 30.00M | -685K | 9.61M | 10.44M | -1.39M |
Cash at end of period | 96.00M | 64.20M | 13.92M | 14.61M | 14.68M | 7.44M |
| Data source | Data source | Data source | Data source | Data source | Data source |